The development of androgen-independent prostate cancer (Q29615650)

Europe PubMed Central

title

The development of androgen-independent prostate cancer (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

30 April 2017

1 reference

Feldman BJ

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

30 April 2017

Feldman D

series ordinal

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

October 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

30 April 2017

published in

Nature Reviews Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

30 April 2017

volume

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

30 April 2017

issue

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

30 April 2017

page(s)

34-45

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

30 April 2017

cites work

Cancer statistics, 2000.

1 reference

7 January 2021

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

1 reference

7 January 2021

Androgen receptor defects: historical, clinical, and molecular perspectives

1 reference

7 January 2021

Mechanisms of androgen receptor activation and function.

1 reference

7 January 2021

Activation of the human androgen receptor through a protein kinase A signaling pathway

1 reference

7 January 2021

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

1 reference

7 January 2021

Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model

1 reference

7 January 2021

Hormone resistance in prostate cancer

1 reference

7 January 2021

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

7 January 2021

Expression, structure, and function of androgen receptor in advanced prostatic carcinoma.

1 reference

7 January 2021

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

7 January 2021

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

1 reference

7 January 2021

Treatment of prostate cancer with gonadotropin-releasing hormone agonists

1 reference

7 January 2021

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

1 reference

7 January 2021

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

1 reference

7 January 2021

Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences

1 reference

7 January 2021

Molecular profiling of human cancer

1 reference

7 January 2021

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

1 reference

7 January 2021

The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer

1 reference

7 January 2021

The Androgen Receptor Gene Mutations Database

1 reference

7 January 2021

Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations

1 reference

7 January 2021

Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone

1 reference

7 January 2021

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

1 reference

7 January 2021

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

1 reference

7 January 2021

Androgen receptor gene mutations in human prostate cancer

1 reference

7 January 2021

Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer.

1 reference

7 January 2021

LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis

1 reference

7 January 2021

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

1 reference

7 January 2021

Androgen-insensitivity syndrome as a possible coactivator disease

1 reference

7 January 2021

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

7 January 2021

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

1 reference

7 January 2021

RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays

1 reference

7 January 2021

Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells

1 reference

7 January 2021

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

1 reference

7 January 2021

Estrogen receptor variants in clinical breast cancer

1 reference

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

7 January 2021

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

1 reference

7 January 2021

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

7 January 2021

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

1 reference

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

7 January 2021

First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report

1 reference

7 January 2021

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

7 January 2021

Cellular survival: a play in three Akts

1 reference

7 January 2021

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

7 January 2021

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway

1 reference

7 January 2021

PTEN: a tumour suppressor that functions as a phospholipid phosphatase

1 reference

7 January 2021

Akt regulates cell survival and apoptosis at a postmitochondrial level

1 reference

7 January 2021

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

1 reference

7 January 2021

Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression

1 reference

7 January 2021

HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway

1 reference

7 January 2021

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

1 reference

7 January 2021

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

1 reference

7 January 2021

Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration

1 reference

7 January 2021

The biology of hormone refractory prostate cancer. Why does it develop?

1 reference

7 January 2021

Stem cell genes in androgen-independent prostate cancer

1 reference

7 January 2021

Novel strategies and therapeutics for the treatment of prostate carcinoma

1 reference

7 January 2021

Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system

1 reference

7 January 2021

Tamoxifen in the treatment of breast cancer

1 reference

7 January 2021

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1041216924

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11900250

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017